San Antonio is one of a handful of U.S. sites that received a 10-year research funding grant from the CDC. But funding for prevention, treatment and ...
News
- Tuberculosis cases rise, but public health agencies say they lack the resources to keep up
- Pasithea Therapeutics Announces Opening of Enrollment in the U.S. for its Phase 1 Trial of PAS-004
Ildefonso Rodriguez M.D., acting as principal investigator for the San Antonio, TX site. There are also three other clinical trial sites in ...
- Former Seagen vice president joins San Diego-area biotech Iambic Therapeutics
Neil Josephson taught at the University of Washington for 10 years before moving into the biotech industry ... San Antonio · San Francisco · Seattle ...
- RADIANT LOGISTICS ANNOUNCES FURTHER EXPANSION OF ITS SERVICE BY AIR ...
Biotechnology · Clinical Trials ... RADIANT LOGISTICS ANNOUNCES FURTHER EXPANSION OF ITS SERVICE BY AIR NETWORK WITH NEW OPERATIONS IN SAN ANTONIO, ...
- Study may open up new ways of approaching metabolic diseases
UT Health San Antonio scientist receives ...